×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ZNTL – zentalis pharmaceuticals, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ZNTL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/12
07:13 am
zntl
Zentalis Pharmaceuticals Announces Key Management Appointments [Yahoo! Finance]
Medium
Report
Zentalis Pharmaceuticals Announces Key Management Appointments [Yahoo! Finance]
12/12
07:00 am
zntl
Zentalis Pharmaceuticals Announces Key Management Appointments
High
Report
Zentalis Pharmaceuticals Announces Key Management Appointments
12/10
02:32 pm
zntl
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
Low
Report
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
12/2
04:35 pm
zntl
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/21
01:14 pm
zntl
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
Low
Report
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
11/21
08:08 am
zntl
Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors [Yahoo! Finance]
Low
Report
Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors [Yahoo! Finance]
11/15
02:07 pm
zntl
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its price target lowered by analysts at Guggenheim from $12.00 to $8.00. They now have a "buy" rating on the stock.
Low
Report
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its price target lowered by analysts at Guggenheim from $12.00 to $8.00. They now have a "buy" rating on the stock.
11/15
08:03 am
zntl
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
High
Report
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
04:00 pm
ZNTL
zentalis pharmaceuticals, inc. - common stock
BEAT
Report
2.3%
zentalis pharmaceuticals, inc. - common stock
8/9/2024
07:00 am
ZNTL
zentalis pharmaceuticals, inc. - common stock
MISS
Report
-13.5%
zentalis pharmaceuticals, inc. - common stock
5/7/2024
07:00 am
ZNTL
zentalis pharmaceuticals, inc. - common stock
BEAT
Report
5.0%
zentalis pharmaceuticals, inc. - common stock
Date
Time
Symbol
Headline
Impact
12/19
04:02 pm
zntl
Form 8-K/A Zentalis Pharmaceuticals For: Dec 17
Low
Report
Form 8-K/A Zentalis Pharmaceuticals For: Dec 17
12/10
12:43 pm
zntl
Form SCHEDULE 13G Zentalis Pharmaceuticals Filed by: Walters William T
Low
Report
Form SCHEDULE 13G Zentalis Pharmaceuticals Filed by: Walters William T
12/6
11:44 am
zntl
Form SCHEDULE 13G/A Zentalis Pharmaceuticals Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Zentalis Pharmaceuticals Filed by: FMR LLC
12/3
07:03 pm
zntl
Form 4 Zentalis Pharmaceuticals For: Dec 02 Filed by: Bruns Ingmar
Low
Report
Form 4 Zentalis Pharmaceuticals For: Dec 02 Filed by: Bruns Ingmar
12/3
07:02 pm
zntl
Form 4 Zentalis Pharmaceuticals For: Dec 02 Filed by: EASTLAND JULIA MARIE
Low
Report
Form 4 Zentalis Pharmaceuticals For: Dec 02 Filed by: EASTLAND JULIA MARIE
11/14
04:20 pm
zntl
Form SC 13G/A Zentalis Pharmaceuticals Filed by: CITADEL ADVISORS LLC
High
Report
Form SC 13G/A Zentalis Pharmaceuticals Filed by: CITADEL ADVISORS LLC
11/13
05:47 pm
zntl
Form 4 Zentalis Pharmaceuticals For: Nov 13 Filed by: Myers Scott Dunseth
Low
Report
Form 4 Zentalis Pharmaceuticals For: Nov 13 Filed by: Myers Scott Dunseth
11/13
05:46 pm
zntl
Form 3 Zentalis Pharmaceuticals For: Nov 13 Filed by: Bruns Ingmar
Low
Report
Form 3 Zentalis Pharmaceuticals For: Nov 13 Filed by: Bruns Ingmar
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
4/2
Form 8-A12B Zentalis Pharmaceuticals
-7.9%
4/30 Zentalis Pharmaceuticals Announces FDA Clearance of IND Application for ZN-d5 for the Treatment of Hematologic Malignancies -2.9%
4/15 Form SC 13G Zentalis Pharmaceuticals Filed by: VIKING GLOBAL INVESTORS LP -2.5%
4/8 Form 4 Zentalis Pharmaceuticals For: Apr 03 Filed by: Shabet Rose Sharon -2.2%
4/9 Form SC 13G Zentalis Pharmaceuticals Filed by: CITADEL ADVISORS LLC -1.7%
4/3 Form 3 Zentalis Pharmaceuticals For: Apr 03 Filed by: Bunker Kevin D. -1.1%
4/30 Zentalis Pharmaceuticals Announces FDA Clearance of IND Application for ZN-d5 for the Treatment of Hematologic Malignancies -2.9%
4/15 Form SC 13G Zentalis Pharmaceuticals Filed by: VIKING GLOBAL INVESTORS LP -2.5%
4/8 Form 4 Zentalis Pharmaceuticals For: Apr 03 Filed by: Shabet Rose Sharon -2.2%
4/9 Form SC 13G Zentalis Pharmaceuticals Filed by: CITADEL ADVISORS LLC -1.7%
4/3 Form 3 Zentalis Pharmaceuticals For: Apr 03 Filed by: Bunker Kevin D. -1.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: